Tudor Investment Corp
RUBY

Tudor Investment Corp’s Rubius Therapeutics, Inc RUBY Stock Holding History

Tudor Investment Corp’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,520
Closed -$113K – 2631
2022
Q1 		$113K Buy
+20,520
New +$130K ﹤0.01% 1824
2021
Q4 		– Sell
-46,076
Closed -$824K – 3184
2021
Q3 		$824K Buy
+46,076
New +$1M 0.01% 1296
2021
Q1 		– Sell
-10,343
Closed -$79K – 1937
2020
Q4 		$79K Sell
10,343
-37,429
-78% -$222K ﹤0.01% 1276
2020
Q3 		$239K Buy
47,772
+30,599
+178% +$162K 0.01% 1077
2020
Q2 		$103K Buy
+17,173
New +$101K 0.01% 1086

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tudor Investment Corp's RUBY Position: Q2 2022 in Review

Tudor Investment Corp sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 20,520 shares — an estimated $113K sold.

Tudor Investment Corp first reported a position in RUBY in Q2 2020 and held it in 5 quarters. The position peaked at $824K in Q3 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • Tudor Investment Corp reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 20,520 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $113K.
  • Tudor Investment Corp first reported a position in Rubius Therapeutics, Inc in Q2 2020 and held it in 5 quarters.
  • Tudor Investment Corp's Rubius Therapeutics, Inc position peaked at $824K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.